Opendata, web and dolomites

C-TCS

A Disruptive Treatment Control Software for Particle Therapy Centers

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 C-TCS project word cloud

Explore the words cloud of the C-TCS project. It provides you a very rough idea of what is the project "C-TCS" about.

safer    radiation    causes    expensive    solution    100m    point    patients    adoption    therapy    shelf    proven    diagnosed    treatment    narrow    annually    neutron    globally    ing    centres    financial    works    radiotherapy    off    charged    pt    particle    surrounding    dose    usable    people    software    external    minimal    damage    acute    universally    lower    times    company    ion    proton    critical    types    women    accelerators    17    burden    facility    configurability    specializing    throughput    slow    building    provides    healthcare    introduction    clinical    death    limited    maintenance    cancer    efficacy    regarding    compact    cosylab    nowadays    vendors    tissue    facilities    incidences    roi    easily    worldwide    2015    synchronizes    25    integrators    adjustments    lives    completion    costly    alternative    5x    manufacturers    slovenian    delivered    men    closed    positive    2025    additional    costing       configurable    gt    operation    puts    sort    employ    centre    tcs    custom    beam   

Project "C-TCS" data sheet

The following table provides information about the project.

Coordinator
COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DD 

Organization address
address: GERBIÄŒEVA ULICA 64
city: LJUBLJANA
postcode: 1000
website: http://www.cosylab.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Slovenia [SI]
 Project website https://www.cosylab.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DD SI (LJUBLJANA) coordinator 50˙000.00

Map

 Project objective

Cancer is one of the leading causes of death nowadays; 1 in every 2 men and 1 in every 3 women will be diagnosed with cancer at some point of their lives. The number of cancer incidences is growing by 2.4% annually, which puts a financial burden on healthcare systems globally. Particle therapy – PT (proton/neutron/positive ion therapy) has been proven to be effective and a safer alternative to other types of external beam radiotherapy as the charged particle dose is delivered in a narrow range and there is minimal damage to surrounding tissue. In 2015, among all patients that were treated for cancer worldwide, 25% were treated using some sort of radiation. However, building PT centres is very costly (>100M €) which has been a crucial factor in the slow adoption of PT facilities. This is likely to change due to introduction to lower cost/compact systems, and, more importantly, growing clinical evidence regarding its efficacy. A critical part of a PT centre is its treatment control system (TCS), the software that synchronizes the operation of all the devices. Currently, PT centre equipment vendors each custom develop their own TCS, which works only with their own equipment, is of limited configurability, closed to adjustments and expensive. Cosylab is a Slovenian company specializing in the field of control systems for particle accelerators with 17 years of experience in the field. We are developing our TCS (C-TCS) as an off-the-shelf product, that is universally usable on all vendors´ (integrators or manufacturers´) equipment. Our solution is easily configurable, available without lead times, and costing 3-5x-less than custom development. Overall, the C-TCS provides better cancer treatment efficacy, lower production and maintenance cost of PT facility, higher throughput of patients (resulting in more people treated). In 5 years after completion of the project (2025) we expect to employ additional 20 people and achieve a ROI of 5.6.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "C-TCS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "C-TCS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More  

SmartDegrees (2020)

First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchain

Read More